Novo Holdings A/S
SEC insider (Form 3/4/5 filer). CIK 0001388325. 10% Owner at Hemab Therapeutics Holdings, Inc. (COAG) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in HELLERUP.
Companies Novo Holdings A/S has filed insider reports for
- Hemab Therapeutics Holdings, Inc. (COAG): 10% Owner
- Avalyn Pharma Inc. (AVLN): 10% Owner
- MapLight Therapeutics, Inc. (MPLT): 10% Owner
Novo Holdings A/S
CIK: 0001388325
Transaction Breakdown
Open Market Buys (P)2 (40.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (60.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 4, 2026COAG
Hemab Therapeutics Holdings, Inc.
ConversionDirect4.2M shares- - May 1, 2026AVLN
Avalyn Pharma Inc.
ConversionDirect3.3M shares- - May 1, 2026AVLN
Avalyn Pharma Inc.
PurchaseDirect555.6K shares at avg. $18.00$10.0M - Oct 28, 2025MPLT
MapLight Therapeutics, Inc.
ConversionDirect2.7M shares- - Oct 28, 2025MPLT
MapLight Therapeutics, Inc.
PurchaseDirect952.9K shares at avg. $17.00$16.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 |  COAG Hemab Therapeutics Holdings, Inc. | Conversion | 4,180,550 | - | $0 | Direct |
| May 1, 2026 |  AVLN Avalyn Pharma Inc. | Conversion | 3,327,734 | - | $0 | Direct |
| May 1, 2026 | AVLN Avalyn Pharma Inc. | Purchase | 555,555 | $18.00 | $9,999,990 | Direct |
| Oct 28, 2025 |  MPLT MapLight Therapeutics, Inc. | Conversion | 2,733,681 | - | - | Direct |
| Oct 28, 2025 | MPLT MapLight Therapeutics, Inc. | Purchase | 952,941 | $17.00 | $16,199,997 | Direct |
1-5 of 5 transactions